Kobiolabs, Inc.

Hyo In Park

In Su Kim

Jin Woo Lee

Hye Jin Kim

Gwang Pyo Ko

June Chul Lee

Tae Wook Nam

Woo Ri Ko

Woon Ki Kim

Dae Hee Han

A strain ofKBL697 and the use thereof are described. The strain ofKBL697 (Accession No. KCTC 13520BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects and a therapeutic effect for intestinal diseases such as irritable bowel syndrome and colitis. Thus, the single strain alone can achieve all the purposes of alleviating allergic diseases and inflammatory diseases and improving intestinal health, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.

Lactobacillus Gasseri KBL697 strain and use thereof

KBL697 strain and use thereof

Growing community of inventors

Seoul, South Korea

Hyo In Park